STRO - SUTRO BIOPHARMA, INC.
IEX Last Trade
1.84
-0.035 -1.902%
Share volume: 7,386
Last Updated: Fri 27 Dec 2024 05:30:26 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.39%
PREVIOUS CLOSE
CHG
CHG%
$1.88
-0.04
-1.87%
Summary score
25%
Profitability
25%
Dept financing
17%
Liquidity
74%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-13.96%
Return on assets
-7.21%
Return on sales
-272.09%
Return on invested capital
116.95%
Total debt ratio
39.73%
Debt ratio change over timeo
-1.2%
Current Ratio
7.16%
Quick Ratio
7.15%
Cash Position Ratio
6.26%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-26.85%
Return on assets
-6.25%
Return on sales
-275.17%
Return on invested capital
151.04%
Total debt ratio
71.15%
Debt ratio change over timeo
-1.24%
Current Ratio
5.07%
Quick Ratio
5.07%
Cash Position Ratio
4.65%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-59.39%
Return on assets
-14.03%
Return on sales
-435.05%
Return on invested capital
189.69%
Total debt ratio
75.7%
Debt ratio change over time
-2.09%
Current Ratio
4.46%
Quick Ratio
4.46%
Cash Position Ratio
3.94%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-83.38%
Return on assets
-92.37%
Return on sales
169.76%
Return on invested capital
-128.8%
Total debt ratio
-120.42%
Debt ratio change over time
-1.2%
Current Ratio
-12.51%
Quick Ratio
-13.41%
Cash Position Ratio
-11.96%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | STRO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -13.96% | 13.79% | 34.47% | 7.43% |
| Return on assets | -7.21% | 2.76% | 3.15% | 5.62% |
| Return on sales | -272.09% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 116.95% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 41% | 60% | 60% |
| Total debt ratio | 39.73% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -1.2% | 308.97% | -6.99% | 1.18% |
| Dept financing | 11% | 50% | 25% | 7% |
| Current Ratio | 5.07% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 5.07% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 4.65% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 7% | 16% | 37% |
| Short-term ratios | STRO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -26.85% | 13.77% | 13.25% | 3.8% |
| Return on assets | -6.25% | 2.43% | 1.89% | 3.09% |
| Return on sales | -275.17% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 151.04% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 65% | 59% | 58% |
| Total debt ratio | 71.15% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -1.24% | 46.38% | -72.08% | 1.51% |
| Dept financing | 19% | 50% | 25% | 7% |
| Current Ratio | 5.07% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 5.07% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 4.65% | 0.36% | 1.28% | 2.93% |
| Liquididy | 73% | 10% | 26% | 64% |